Logo image of EXOZ

EXOZYMES INC (EXOZ) Stock Price, Forecast & Analysis

USA - NASDAQ:EXOZ - US4618741098 - Common Stock

14.52 USD
-0.4 (-2.68%)
Last: 11/18/2025, 8:00:02 PM
13.5 USD
-1.02 (-7.02%)
After Hours: 11/4/2025, 8:21:19 PM

EXOZ Key Statistics, Chart & Performance

Key Statistics
Market Cap121.82M
Revenue(TTM)N/A
Net Income(TTM)-7.71M
Shares8.39M
Float2.37M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.69
PEN/A
Fwd PEN/A
Earnings (Next)03-31 2026-03-31
IPO2024-11-13
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


EXOZ short term performance overview.The bars show the price performance of EXOZ in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40

EXOZ long term performance overview.The bars show the price performance of EXOZ in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of EXOZ is 14.52 USD. In the past month the price increased by 15.24%.

EXOZYMES INC / EXOZ Daily stock chart

EXOZ Latest News, Press Relases and Analysis

EXOZ Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 24.75 413.15B
AMGN AMGEN INC 15.73 185.19B
GILD GILEAD SCIENCES INC 15.53 157.81B
VRTX VERTEX PHARMACEUTICALS INC 25.09 111.66B
REGN REGENERON PHARMACEUTICALS 16.12 76.88B
ALNY ALNYLAM PHARMACEUTICALS INC 906.47 60.60B
INSM INSMED INC N/A 42.62B
NTRA NATERA INC N/A 29.32B
BIIB BIOGEN INC 10.09 24.75B
UTHR UNITED THERAPEUTICS CORP 18.06 21.56B
INCY INCYTE CORP 16.18 20.29B
NBIX NEUROCRINE BIOSCIENCES INC 33.17 13.75B

About EXOZ

Company Profile

EXOZ logo image eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

Company Info

EXOZYMES INC

750 Royal Oaks Dr

Monrovia California CALIFORNIA US

Employees: 31

EXOZ Company Website

Phone: 16264151488

EXOZYMES INC / EXOZ FAQ

What does EXOZYMES INC do?

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.


Can you provide the latest stock price for EXOZYMES INC?

The current stock price of EXOZ is 14.52 USD. The price decreased by -2.68% in the last trading session.


Does EXOZ stock pay dividends?

EXOZ does not pay a dividend.


What is the ChartMill technical and fundamental rating of EXOZ stock?

EXOZ has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


How is the valuation of EXOZYMES INC (EXOZ) based on its PE ratio?

EXOZYMES INC (EXOZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.69).


When does EXOZYMES INC (EXOZ) report earnings?

EXOZYMES INC (EXOZ) will report earnings on 2026-03-31.


Can you provide the ownership details for EXOZ stock?

You can find the ownership structure of EXOZYMES INC (EXOZ) on the Ownership tab.


EXOZ Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to EXOZ.


Chartmill TA Rating
Chartmill Setup Rating

EXOZ Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EXOZ. The financial health of EXOZ is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EXOZ Financial Highlights

Over the last trailing twelve months EXOZ reported a non-GAAP Earnings per Share(EPS) of -1.69. The EPS decreased by -256.1% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -79.66%
ROE -106.54%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-68.34%
Sales Q2Q%N/A
EPS 1Y (TTM)-256.1%
Revenue 1Y (TTM)N/A

EXOZ Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

EXOZ Ownership

Ownership
Inst Owners0.9%
Ins Owners24.86%
Short Float %0.61%
Short Ratio5.2